Unknown

Dataset Information

0

PH-responsive and hyaluronic acid-functionalized metal-organic frameworks for therapy of osteoarthritis.


ABSTRACT: Drug therapy of osteoarthritis (OA) is limited by the short retention and lacking of stimulus-responsiveness after intra-articular (IA) injection. The weak acid microenvironment in joint provides a potential trigger for controlled drug release systems in the treatment of OA. Herein, we developed an pH-responsive metal?-?organic frameworks (MOFs) system modified by hyaluronic acid (HA) and loaded with an anti-inflammatory protocatechuic acid (PCA), designated as MOF@HA@PCA, for the therapy of OA. Results demonstrated that MOF@HA@PCA could smartly respond to acidic conditions in OA microenvironment and gradually release PCA, which could remarkably reduce synovial inflammation in both IL-1? induced chondrocytes and the OA joints. MOF@HA@PCA also down-regulated the expression of inflammatory markers of OA and promoted the expression of cartilage-specific makers. This work may provide a new insight for the design of efficient nanoprobes for precision theranostics of OA .

SUBMITTER: Xiong F 

PROVIDER: S-EPMC7523381 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

pH-responsive and hyaluronic acid-functionalized metal-organic frameworks for therapy of osteoarthritis.

Xiong Feng F   Qin Zainen Z   Chen Haimin H   Lan Qiumei Q   Wang Zetao Z   Lan Nihan N   Yang Yuan Y   Zheng Li L   Zhao Jinmin J   Kai Dan D  

Journal of nanobiotechnology 20200929 1


Drug therapy of osteoarthritis (OA) is limited by the short retention and lacking of stimulus-responsiveness after intra-articular (IA) injection. The weak acid microenvironment in joint provides a potential trigger for controlled drug release systems in the treatment of OA. Herein, we developed an pH-responsive metal - organic frameworks (MOFs) system modified by hyaluronic acid (HA) and loaded with an anti-inflammatory protocatechuic acid (PCA), designated as MOF@HA@PCA, for the therapy of OA.  ...[more]

Similar Datasets

| S-EPMC6134922 | biostudies-literature
| S-EPMC5621505 | biostudies-other
| S-EPMC4728024 | biostudies-literature
| S-EPMC7221552 | biostudies-literature
| S-EPMC8456408 | biostudies-literature
| S-EPMC6085730 | biostudies-literature
| S-EPMC5364997 | biostudies-literature
| S-EPMC6820732 | biostudies-literature
| S-EPMC5843951 | biostudies-literature
| S-EPMC4156865 | biostudies-literature